Product Information
NATEGLINIDE 120 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.2345 per EA under NDC 75834020601. Its NADAC has been published 340 times since Feb 19, 2020.
FDA first approved this application on Apr 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
120 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834020601
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NATEGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206432FDA Approved
4/19/2019
TE Code
AB
On Market Since
9/25/2019
Pharmacological Classes
Price Statistics
The NADAC for NATEGLINIDE 120 MG TABLET has been published 340 times since Feb 19, 2020, and over the history we have for it it has declined 43.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2345 per EA |
|---|---|
| All-time high | $0.4240 (Apr 15, 2020) |
| All-time low | $0.2154 (Nov 22, 2023) |
| 52-week high | $0.2609 |
| 52-week low | $0.2345 |
| Median price | $0.2983 |
| Average price | $0.3019 |
| Largest weekly change | -30.0% (Nov 22, 2023) |
| Weeks tracked | 340 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NATEGLINIDE 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NATEGLINIDE 120 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.2345 per EA (NDC 75834020601), effective Aug 19, 2026.
How has the price of NATEGLINIDE 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for NATEGLINIDE 120 MG TABLET has declined 43.5%. It has been tracked across 340 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for NATEGLINIDE 120 MG TABLET?
Since Feb 19, 2020, the NADAC for NATEGLINIDE 120 MG TABLET has ranged from a low of $0.2154 (Nov 22, 2023) to a high of $0.4240 (Apr 15, 2020), with a median of $0.2983 per EA.
Are there cheaper alternatives to NATEGLINIDE 120 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NATEGLINIDE 120 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NATEGLINIDE 120 MG TABLET?
NATEGLINIDE 120 MG TABLET (NDC 75834020601) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.